Replacing a leaky aortic valve without open-heart surgery
Part of Heart & circulation clinical trials.
This study tests a less invasive procedure to replace a leaky aortic valve in people who can't have open-heart surgery. The goal is to help your heart pump better and reduce symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have severe aortic regurgitation, meaning your aortic valve doesn't close properly and blood leaks backward into your heart.
- You have symptoms (like breathlessness or fatigue) or signs that your heart is struggling (like enlarged heart or weak pumping).
- Your doctors agree that a minimally invasive valve replacement (TAVR) is the best choice, especially if open surgery is too risky.
- You do not have an active heart infection or severe body-wide infection.
- Your aorta does not need surgery for other problems like a bulge or tear.
- The size of your heart valve fits the replacement valve used in this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a catheter-based procedure to replace a severely leaking aortic valve without open-heart surgery. It may help people who have symptoms or heart damage from a leaky valve and are not good candidates for surgery.
This trial tests whether a 3D computer simulation can help guide a less invasive procedure (TAVR) to replace a leaky aortic valve. It may be an option for people with severe aortic regurgitation who are at least 65 years old.
This study tests a new valve replacement for people with severe aortic regurgitation (leaky heart valve) who are not good candidates for open surgery. The valve is put in through a small tube in the leg, which may be less risky for high-risk patients.
This study is testing a new, less invasive heart valve system (TaurusTrio) for people with severe aortic regurgitation (a leaky aortic valve) who cannot have open-heart surgery. It aims to see if the valve is safe and works well to improve symptoms.
This trial compares a new less-invasive valve replacement (Trilogy TAVR) with standard open-heart surgery for people with significant aortic regurgitation. It aims to see which treatment works better for patients who are eligible for both procedures.
This study tests whether a less invasive valve replacement (TAVI) can be done safely in hospitals that don't have a full heart surgery team on site. If you have severe aortic stenosis and are 70 or older, this trial might offer a new option with a shorter recovery than open-heart surgery.
Hear when a new Aortic Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.